Sign Out
Hypersensitivity to empagliflozin or any of the excipients in JARDIANCE.
Renally impaired patients with eGFR less than 45 mL/min/1.73m2, severe renal impairment, end-stage renal disease and patients on dialysis. The efficacy of JARDIANCE is dependent on renal function (see PRECAUTIONS).
In case of rare hereditary conditions that may be incompatible with an excipient of the product, the use of the product is contraindicated. The 10 mg tablet contains 162.5 mg of lactose and the 25 mg tablet contains 113 mg of lactose per maximum recommended daily dose. Patients with the rare hereditary conditions of galactose intolerance e.g. galactosaemia should not take this medicine.
